Howard wrote:
Of course Q3 may show a wonderful improvement, but for the moment despite their increase in China, Tesla sales have dropped significantly overall.
regards
Howard
No need to check the TSLA website, the data is all on that spreadsheet I posted a snapshot of several days ago. You can add up the periods as you choose, from the repeat below.
Even if Covid-19 were not an issue, then all things being equal we would expect any auto mfg to have a worse H1-2020 than an H2-2019 due to the inclusion of the Q1 in which sales are always slow, and so that is when plant shutdowns are scheduled. However this was not intended to be a "all things equal" H1 for TSLA as (from memory) it should have been ramping prod at Shanghai, and starting to bring further capacity online at Fremont, so in this particular case the H1 should have been better than the preceding H2. However Covid-19 was an issue and so that wrecked those plans.
I don't care about trying to score he said / she said points. My take is that by comparison with other auto mfg TSLA came through the H1 Covid-19 issues reasonably well. Not ideally, but adequately.
What is important for me is the forwards-looking action. Can they keep up the overall growth rates that the price is predicated on. That will require both production capacity increase and sales demand to increase in step with each other, and for product improvements and product introductions to all proceed smoothly. This is not a competition-free world and so TSLA have to execute very well to justify their price.
regards, dspp